Kabita Nanda

Pediatric Rheumatology

4800 Sand Point Way Northeast
Seattle, WA 98105

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Uveitis in pediatric idiopathic orbital inflammatory syndrome.

Uveitis in pediatric idiopathic orbital inflammatory syndrome.

Journal: American journal of ophthalmology case reports

Published: December 24, 2025

Cognitive Behavioral Therapy for Youth With Childhood-Onset Lupus: A Randomized Clinical Trial.

Cognitive Behavioral Therapy for Youth With Childhood-Onset Lupus: A Randomized Clinical Trial.

Journal: Arthritis care & research

Published: June 09, 2025

25 Years of Biologics for the Treatment of Pediatric Rheumatic Disease: Advances in Prognosis and Ongoing Challenges.

25 Years of Biologics for the Treatment of Pediatric Rheumatic Disease: Advances in Prognosis and Ongoing Challenges.

Journal: Arthritis care & research

Published: July 22, 2024

Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research.

Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research.

Journal: Pediatric rheumatology online journal

Published: May 03, 2024

Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis.

Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis.

Journal: Arthritis care & research

Published: March 19, 2024

A multi-site pilot randomized clinical trial of the Treatment and Education Approach for Childhood-onset Lupus (TEACH) program: study design and COVID-19 adaptations.

A multi-site pilot randomized clinical trial of the Treatment and Education Approach for Childhood-onset Lupus (TEACH) program: study design and COVID-19 adaptations.

Journal: Pediatric rheumatology online journal

Published: December 20, 2022

Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives.

Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives.

Journal: Annals of medicine

Published: July 05, 2022

Correction to: Heme oxygenase-1 deficiency presenting with interstitial lung disease and hemophagocytic flares.

Correction to: Heme oxygenase-1 deficiency presenting with interstitial lung disease and hemophagocytic flares.

Journal: Pediatric rheumatology online journal

Published: March 15, 2022

Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.

Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.

Journal: Lancet (London, England)

Published: March 01, 2021

Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.

Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.

Journal: Rheumatology (Oxford, England)

Published: July 28, 2020

Heme oxygenase-1 deficiency presenting with interstitial lung disease and hemophagocytic flares.

Heme oxygenase-1 deficiency presenting with interstitial lung disease and hemophagocytic flares.

Journal: Pediatric rheumatology online journal

Published: March 06, 2020

Juvenile Dermatomyositis (JDM) Complicated by Thrombotic Thrombocytopenic Purpura (TTP) and Purtscher's Retinopathy Responsive to Rituximab: Case Report and Literature Review.

Juvenile Dermatomyositis (JDM) Complicated by Thrombotic Thrombocytopenic Purpura (TTP) and Purtscher's Retinopathy Responsive to Rituximab: Case Report and Literature Review.

Journal: Frontiers in pediatrics

Published: September 26, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026